Syndax And Merck Announce First Patients Dosed In Phase 1b/2 Clinical Trial Of Entinostat And Keytruda®

September 28, 2015
PDF Version
Syndax And Merck Announce First Patients Dosed In Phase 1b/2 Clinical Trial Of Entinostat And Keytruda®